Headquarters: Columbia, Md.
Business: The company is conducting a Phase III clinical trial of a stem-cell therapy used to treat graft vs. host disease, in which the immune cells from a transplanted bone marrow attack the cells of the recipient.
Headquarters: Cleveland
Business: The start-up is developing stem-cell therapies to treat cardiovascular and neurological diseases and cancer.
Headquarters: Durham, N.C.
Business: The company just started a Phase III clinical trial of a stem-cell treatment to improve umbilical cord blood transplants for kids with inherited metabolic diseases.
Just as Lawrence Kazmerski, a top official at the National Renewable Energy Laboratory, was about to give the keynote address at the University of Minnesota's annual E3 conference at the RiverCentre in St. Paul, the lights went out, bathing the audience in darkness and a deep sense of irony.
Comment on this story | Be the first to comment | Hide reader comments